Tuesday, October 7, 2014

NanoViricides CEO, Eugene Seymour, MD, MPH, Invited to Discuss the...

... and future Ebola epidemics. The highly customizable nanomedicine cGMP capable pilot scale manufacturing facility in Shelton, CT, will be able to supply all of the nanoviricides drug candidates in quantities needed for human clinical trials. As of ...



via Shelton Newswire http://ift.tt/1s6ouI0

No comments:

Post a Comment

Popular Shelton Roundup Posts

More Shelton News

Connecticut News

National News

World News

Business News

Sci/Tech News

Entertainment News

Sports News

Health News